| scholarly article | Q13442814 |
| P2093 | author name string | Bo Yu | |
| Jielin Pu | |||
| Qiang Li | |||
| Rong Zhang | |||
| Lihong Wang | |||
| Zhongyu Li | |||
| Ning Wang | |||
| Yue Li | |||
| Rongrong Wang | |||
| Baofeng Yang | |||
| Hongli Shan | |||
| Yanjie Lu | |||
| Kang Li | |||
| Jing Ai | |||
| Zhuqin Li | |||
| Jundong Jiao | |||
| P2860 | cites work | Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart | Q28279009 |
| MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts | Q28291882 | ||
| Transcriptional activation by stimulating protein 1 and post-transcriptional repression by muscle-specific microRNAs of IKs-encoding genes and potential implications in regional heterogeneity of their expressions | Q34620520 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial infarction | Q12152 |
| microRNA | Q310899 | ||
| biomarker | Q864574 | ||
| acute myocardial infarction | Q18558122 | ||
| P304 | page(s) | 73-7 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction | |
| P478 | volume | 391 |
| Q37629842 | A Signature of Circulating microRNAs Predicts the Susceptibility of Acute Mountain Sickness |
| Q35041452 | A combination of Let-7d, Let-7g and Let-7i serves as a stable reference for normalization of serum microRNAs |
| Q54399995 | A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis |
| Q37555805 | A plasma microRNA signature as a biomarker for acquired aplastic anemia |
| Q37700310 | A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction |
| Q28275588 | A translational study of circulating cell-free microRNA-1 in acute myocardial infarction |
| Q35820027 | A translational study of urine miRNAs in acute myocardial infarction |
| Q36342169 | Advances in exploring the role of microRNAs in the pathogenesis, diagnosis and therapy of cardiac diseases in China |
| Q21202158 | An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma |
| Q59791985 | Anabolic Androgenic Steroids: Searching New Molecular Biomarkers |
| Q33624961 | Aneurysm-Specific miR-221 and miR-146a Participates in Human Thoracic and Abdominal Aortic Aneurysms |
| Q36806610 | Angiotensin receptor type 1 single nucleotide polymorphism 1166A/C is associated with malignant arrhythmias and altered circulating miR-155 levels in patients with chronic heart failure. |
| Q38264294 | Application of microRNAs in diagnosis and treatment of cardiovascular disease |
| Q29547772 | Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma |
| Q44243789 | Assessment of microRNAs in patients with unstable angina pectoris |
| Q36193626 | Association of plasma MiR-17-92 with dyslipidemia in patients with coronary artery disease |
| Q37974077 | Atrial remodeling in atrial fibrillation and association between microRNA network and atrial fibrillation |
| Q40149936 | Bioinformatics Analyses of Differentially Expressed Genes Associated with Acute Myocardial Infarction |
| Q47139124 | Biomarkers identification for acute myocardial infarction detection via weighted gene co-expression network analysis |
| Q37974079 | Cardinal roles of miRNA in cardiac development and disease |
| Q30387502 | Cardiovascular and Cerebrovascular Disease Associated microRNAs Are Dysregulated in Placental Tissues Affected with Gestational Hypertension, Preeclampsia and Intrauterine Growth Restriction |
| Q38165939 | Cardiovascular extracellular microRNAs: emerging diagnostic markers and mechanisms of cell-to-cell RNA communication |
| Q37685243 | Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease |
| Q33732120 | Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions |
| Q34426839 | Cell-free nucleic acids as non-invasive biomarkers of gynecological cancers, ovarian, endometrial and obstetric disorders and fetal aneuploidy |
| Q92734019 | Challenges in Using Circulating Micro-RNAs as Biomarkers for Cardiovascular Diseases |
| Q37473142 | Circulating Cell and Plasma microRNA Profiles Differ between Non-ST-Segment and ST-Segment-Elevation Myocardial Infarction |
| Q38648011 | Circulating Extracellular microRNA in Systemic Autoimmunity |
| Q42570968 | Circulating Long Noncoding RNA UCA1 as a Novel Biomarker of Acute Myocardial Infarction |
| Q41338350 | Circulating MicroRNA Let-7d in Attention-Deficit/Hyperactivity Disorder |
| Q38574032 | Circulating MicroRNA and Long Noncoding RNA as Biomarkers of Cardiovascular Diseases |
| Q38700900 | Circulating MicroRNA in patients with repaired tetralogy of Fallot. |
| Q35968528 | Circulating MicroRNA-26a in Plasma and Its Potential Diagnostic Value in Gastric Cancer |
| Q54959799 | Circulating MicroRNAs in Young Patients with Acute Coronary Syndrome. |
| Q26800274 | Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Cardiovascular and Cerebrovascular Diseases |
| Q37209930 | Circulating Organ-Specific MicroRNAs Serve as Biomarkers in Organ-Specific Diseases: Implications for Organ Allo- and Xeno-Transplantation |
| Q36688493 | Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction. |
| Q64953291 | Circulating exosomal miR-92b-5p is a promising diagnostic biomarker of heart failure with reduced ejection fraction patients hospitalized for acute heart failure. |
| Q97439633 | Circulating high-sensitivity troponin T and microRNAs as markers of myocardial damage during childhood leukaemia treatment |
| Q37370980 | Circulating levels of inflammation-associated miR-155 and endothelial-enriched miR-126 in patients with end-stage renal disease |
| Q40291390 | Circulating long non-coding RNAs NRON and MHRT as novel predictive biomarkers of heart failure |
| Q37701713 | Circulating miR-1 as a potential biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients |
| Q37022196 | Circulating miR-21, miR-378, and miR-940 increase in response to an acute exhaustive exercise in chronic heart failure patients |
| Q43856327 | Circulating miRNA as novel markers for diastolic dysfunction |
| Q58611996 | Circulating miRNA measurements are reflective of cholesterol-based changes in rainbow trout (Oncorhynchus mykiss) |
| Q37028574 | Circulating miRNAs reflect early myocardial injury and recovery after heart transplantation |
| Q38095110 | Circulating miRNAs: novel biomarkers of acute coronary syndrome? |
| Q38045189 | Circulating miRNAs: reflecting or affecting cardiovascular disease? |
| Q51067836 | Circulating microRNA as a Novel Biomarker for Pulmonary Arterial Hypertension Due to Congenital Heart Disease. |
| Q89444419 | Circulating microRNA expression profiling and bioinformatics analysis of dysregulated microRNAs of patients with coronary artery disease |
| Q37254246 | Circulating microRNA is a biomarker of pediatric Crohn disease. |
| Q60920330 | Circulating microRNA-1 in the diagnosis and predicting prognosis of patients with chest pain: a prospective cohort study |
| Q46466927 | Circulating microRNA-126 increases after different forms of endurance exercise in healthy adults |
| Q34685379 | Circulating microRNA-19a as a potential novel biomarker for diagnosis of acute myocardial infarction |
| Q34612138 | Circulating microRNAs and aerobic fitness--the HUNT-Study |
| Q24606701 | Circulating microRNAs are new and sensitive biomarkers of myocardial infarction |
| Q86809686 | Circulating microRNAs as Biomarkers in Cardiovascular Diseases |
| Q38040050 | Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases |
| Q27001706 | Circulating microRNAs as mirrors of acute coronary syndromes: MiRacle or quagMire? |
| Q37662409 | Circulating microRNAs as novel and sensitive biomarkers of acute myocardial Infarction |
| Q38125100 | Circulating microRNAs as novel biomarkers for the early diagnosis of acute coronary syndrome. |
| Q38274805 | Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets |
| Q37672902 | Circulating microRNAs in patients with ST-elevation myocardial infarction |
| Q38343033 | Circulating microRNAs in response to exercise. |
| Q34246016 | Circulating microRNAs involved in multiple sclerosis |
| Q30388187 | Circulating microRNAs predict future fatal myocardial infarction in healthy individuals - The HUNT study. |
| Q26862733 | Circulating microRNAs: a potential role in diagnosis and prognosis of acute myocardial infarction |
| Q37967181 | Circulating microRNAs: novel biomarkers for cardiovascular diseases |
| Q58816149 | Circulating microRNAs: novel biomarkers for cardiovascular diseases? |
| Q59792850 | Circulating small non-coding RNAs associated with age, sex, smoking, body mass and physical activity |
| Q89598626 | Circulatory miR-133b and miR-21 as Novel Biomarkers in Early Prediction and Diagnosis of Coronary Artery Disease |
| Q64890256 | Clinical Value of Circulating Microribonucleic Acids miR-1 and miR-21 in Evaluating the Diagnosis of Acute Heart Failure in Asymptomatic Type 2 Diabetic Patients. |
| Q34002423 | Comparative RNA-sequencing analysis of myocardial and circulating small RNAs in human heart failure and their utility as biomarkers |
| Q36555021 | Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acute myocardial infarction |
| Q34179703 | Comparison of plasma microRNA-1 and cardiac troponin T in early diagnosis of patients with acute myocardial infarction |
| Q35019922 | Consolidated and emerging inflammatory markers in coronary artery disease |
| Q38136336 | Conventional and novel diagnostic biomarkers of acute myocardial infarction: a promising role for circulating microRNAs |
| Q37543416 | Coronary heart disease alters intercellular communication by modifying microparticle-mediated microRNA transport |
| Q28072364 | Current Technologies and Recent Developments for Screening of HPV-Associated Cervical and Oropharyngeal Cancers |
| Q55668859 | Deciphering Non-coding RNAs in Cardiovascular Health and Disease. |
| Q42777770 | Defining a microRNA-mRNA interaction map for calcineurin inhibitor induced nephrotoxicity |
| Q24289207 | Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies |
| Q34552832 | Detection and comparison of microRNA expression in the serum of Doberman Pinschers with dilated cardiomyopathy and healthy controls |
| Q34613446 | Differential plasma microRNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis B |
| Q34533056 | Discovery of MicroRNAs associated with myogenesis by deep sequencing of serial developmental skeletal muscles in pigs |
| Q34776270 | Distinct microRNAs expression profile in primary biliary cirrhosis and evaluation of miR 505-3p and miR197-3p as novel biomarkers. |
| Q64929658 | Downregulation of microRNA-1 attenuates glucose-induced apoptosis by regulating the liver X receptor α in cardiomyocytes. |
| Q87269128 | Dysregulated miR1254 and miR579 for cardiotoxicity in patients treated with bevacizumab in colorectal cancer |
| Q36389315 | Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs |
| Q34009709 | Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus. |
| Q92838334 | Elevated circulating miR-126-3p expression in patients with acute myocardial infarction: its diagnostic value |
| Q39190427 | Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy |
| Q39315669 | Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy |
| Q64103994 | Emodin protects H9c2 cells from hypoxia-induced injury by up-regulating miR-138 expression |
| Q26853220 | Epigenetic mechanisms underlying cardiac degeneration and regeneration |
| Q36791634 | Exosome-mediated microRNA transfer plays a role in radiation-induced bystander effect |
| Q29614234 | Export of microRNAs and microRNA-protective protein by mammalian cells |
| Q35839869 | Expression Patterns of miRNA-423-5p in the Serum and Pericardial Fluid in Patients Undergoing Cardiac Surgery |
| Q35387464 | Expression of circulating microRNA-1 and microRNA-133 in pediatric patients with tachycardia |
| Q61455866 | Expression profile and biological function of miR-455-5p in colorectal carcinoma |
| Q35417685 | Extracellular microRNA: a new source of biomarkers |
| Q38648005 | Extracellular microRNAs in Membrane Vesicles and Non-vesicular Carriers. |
| Q35513779 | Extracellular/circulating microRNAs and their potential role in cardiovascular disease. |
| Q38531858 | Gene Expression Signatures and the Spectrum of Coronary Artery Disease |
| Q35667958 | Ginsenoside-Rb1 Protects Hypoxic- and Ischemic-Damaged Cardiomyocytes by Regulating Expression of miRNAs |
| Q34016595 | Haemolysis during sample preparation alters microRNA content of plasma. |
| Q64112575 | Human Brain Injury and miRNAs: An Experimental Study |
| Q36025533 | Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction |
| Q34140925 | Human traumatic brain injury alters plasma microRNA levels. |
| Q34082010 | HypoxamiR regulation and function in ischemic cardiovascular diseases. |
| Q41331160 | Identification and characterization of novel serum microRNAs in unstable angina pectoris and subclinical atherosclerotic patients |
| Q59793852 | Identification of drug repurposing candidates based on a miRNA-mediated drug and pathway network for cardiac hypertrophy and acute myocardial infarction |
| Q38432204 | Identification of exosomal muscle-specific miRNAs in serum of myotonic dystrophy patients relating to muscle disease progress. |
| Q38725872 | Identification of microRNAs as diagnostic biomarkers for acute myocardial infarction in Asian populations: A systematic review and meta-analysis |
| Q45793264 | Identification of microRNAs as potential cellular monocytic biomarkers in the early phase of myocardial infarction: a pilot study |
| Q45366595 | Identification of suitable reference genes for qRT-PCR analysis of circulating microRNAs in hepatitis B virus-infected patients |
| Q26746063 | Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review |
| Q38431796 | Identifying differential miR and gene consensus patterns in peripheral blood of patients with cardiovascular diseases from literature data. |
| Q44781657 | Identifying key genes associated with acute myocardial infarction |
| Q41582023 | Inhibition of microRNA-214-5p promotes cell survival and extracellular matrix formation by targeting collagen type IV alpha 1 in osteoblastic MC3T3-E1 cells |
| Q64379074 | Insulin ameliorates miR-1-induced injury in H9c2 cells under oxidative stress via Akt activation |
| Q26991755 | Issues and prospects of microRNA-based biomarkers in blood and other body fluids |
| Q41628074 | Kinetics of Circulating MicroRNAs in Response to Cardiac Stress in Patients With Coronary Artery Disease |
| Q58767620 | Lycium barbarum polysaccharides restore adverse structural remodelling and cardiac contractile dysfunction induced by overexpression of microRNA-1 |
| Q42820229 | Metabolism of kurarinone by human liver microsomes and its effect on cytotoxicity |
| Q27027950 | Methodological challenges in utilizing miRNAs as circulating biomarkers |
| Q36144748 | MiR-139-5p is associated with inflammatory regulation through c-FOS suppression, and contributes to the progression of primary biliary cholangitis. |
| Q27307894 | MiR-155 Enhances Insulin Sensitivity by Coordinated Regulation of Multiple Genes in Mice |
| Q35492752 | MiR-181a: a potential biomarker of acute muscle wasting following elective high-risk cardiothoracic surgery |
| Q36191643 | MiR-21 is involved in radiation-induced bystander effects |
| Q64066023 | MiR-423 is differentially expressed in patients with stable and unstable coronary artery disease: A pilot study |
| Q35095427 | MiRNAs as biomarkers of myocardial infarction: a meta-analysis |
| Q38286294 | MiRNAs as potential molecular targets in heart failure |
| Q47140141 | MiRroring the Multiple Potentials of MicroRNAs in Acute Myocardial Infarction |
| Q35110023 | MicroRNA Expression Profile in CAD Patients and the Impact of ACEI/ARB. |
| Q36602813 | MicroRNA Regulation of Atherosclerosis |
| Q35653724 | MicroRNA Stability in Postmortem FFPE Tissues: Quantitative Analysis Using Autoptic Samples from Acute Myocardial Infarction Patients |
| Q38510942 | MicroRNA as Biomarkers and Diagnostics. |
| Q47811628 | MicroRNA expression profiles and networks in placentas complicated with selective intrauterine growth restriction |
| Q34628003 | MicroRNA expression profiling in PBMCs: a potential diagnostic biomarker of chronic hepatitis C |
| Q88250663 | MicroRNA profiling in kidney disease: Plasma versus plasma-derived exosomes |
| Q38011295 | MicroRNA regulation of lipid metabolism |
| Q51652483 | MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction |
| Q35529032 | MicroRNA-1 aggravates cardiac oxidative stress by post-transcriptional modification of the antioxidant network |
| Q57492464 | MicroRNA-1 and Circulating Microvesicles Mediate the Protective Effects of Dantonic in Acute Myocardial Infarction Rat Models |
| Q34412493 | MicroRNA-1 in Cardiac Diseases and Cancers |
| Q57789910 | MicroRNA-126 modulates endothelial SDF-1 expression and mobilization of Sca-1+/Lin− progenitor cells in ischaemia |
| Q35298762 | MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism |
| Q91606872 | MicroRNA-153 impairs presynaptic plasticity by blocking vesicle release following chronic brain hypoperfusion |
| Q91852688 | MicroRNA-1976 regulates degeneration of the sinoatrial node by targeting Cav1.2 and Cav1.3 ion channels |
| Q28115561 | MicroRNA-19b functions as potential anti-thrombotic protector in patients with unstable angina by targeting tissue factor |
| Q92324485 | MicroRNA-204 as an Indicator of Severity of Pulmonary Hypertension in Children with Congenital Heart Disease Complicated with Pulmonary Hypertension |
| Q37029400 | MicroRNA-208b Alleviates Post-Infarction Myocardial Fibrosis in a Rat Model by Inhibiting GATA4. |
| Q92544047 | MicroRNA-451b Participates in Coronary Heart Disease By Targeting VEGFA |
| Q38404768 | MicroRNA208 family in cardiovascular diseases: therapeutic implication and potential biomarker |
| Q37017196 | MicroRNA: A new therapeutic strategy for cardiovascular diseases |
| Q34341531 | MicroRNAs Control Macrophage Formation and Activation: The Inflammatory Link between Obesity and Cardiovascular Diseases |
| Q51787118 | MicroRNAs Mediate Beneficial Effects of Exercise in Heart. |
| Q34927574 | MicroRNAs and cardiovascular diseases |
| Q59104729 | MicroRNAs and cardiovascular diseases |
| Q38110225 | MicroRNAs as biomarkers for ischemic heart disease |
| Q27000432 | MicroRNAs as biomarkers for myocardial infarction |
| Q38201510 | MicroRNAs as potential circulating biomarkers of drug-induced liver injury: key current and future issues for translation to humans |
| Q33821302 | MicroRNAs expression profiles in cardiovascular diseases |
| Q28076541 | MicroRNAs in Coronary Heart Disease: Ready to Enter the Clinical Arena? |
| Q34760006 | MicroRNAs in cardiac disease |
| Q34988737 | MicroRNAs in cardiovascular disease |
| Q37766210 | MicroRNAs in cardiovascular diseases: biology and potential clinical applications |
| Q39304689 | MicroRNAs in injury and repair |
| Q38161836 | MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine. |
| Q38888119 | MicroRNAs, heart failure, and aging: potential interactions with skeletal muscle. |
| Q38765883 | MicroRNAs: Biomarkers, Diagnostics, and Therapeutics |
| Q35667644 | MicroRNAs: Novel Regulators of the Heart. |
| Q38166071 | Molecular basis of cancer-therapy-induced cardiotoxicity: introducing microRNA biomarkers for early assessment of subclinical myocardial injury |
| Q88727450 | Myocardial infarction-induced hippocampal microtubule damage by cardiac originating microRNA-1 in mice |
| Q34605730 | Non-Coding RNAs: Functional Aspects and Diagnostic Utility in Oncology |
| Q88482868 | Non-coding RNAs as biomarkers for acute myocardial infarction |
| Q28081466 | Noncoding RNA in age-related cardiovascular diseases |
| Q27026348 | Novel insights into miRNA in lung and heart inflammatory diseases |
| Q28088373 | Novel methodologies for biomarker discovery in atherosclerosis |
| Q57452741 | Opportunities for microRNAs in the Crowded Field of Cardiovascular Biomarkers |
| Q33551604 | Over-expression of microRNA-1 causes arrhythmia by disturbing intracellular trafficking system |
| Q59800208 | Overexpression of miR-1 in the heart attenuates hippocampal synaptic vesicle exocytosis by the posttranscriptional regulation of SNAP-25 through the transportation of exosomes |
| Q54304118 | Overexpression of microRNA-1 impairs cardiac contractile function by damaging sarcomere assembly. |
| Q51701422 | P38 MAPK/miR-1 are involved in the protective effect of EGCG in high glucose-induced Cx43 downregulation in neonatal rat cardiomyocytes. |
| Q34027681 | Plasma levels of microRNA-499 provide an early indication of perioperative myocardial infarction in coronary artery bypass graft patients |
| Q34155097 | Plasma miR-216a as a potential marker of pancreatic injury in a rat model of acute pancreatitis |
| Q37360422 | Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis |
| Q28545216 | Plasma microRNAs as potential noninvasive biomarkers for in-stent restenosis |
| Q28743899 | Platelets in patients with premature coronary artery disease exhibit upregulation of miRNA340* and miRNA624* |
| Q34121527 | Polymorphism in miRNA-1 target site and circulating miRNA-1 phenotype are associated with the decreased risk and prognosis of coronary artery disease |
| Q33936328 | Pre-profiling factors influencing serum microRNA levels |
| Q35792720 | Profiling of circulating microRNAs: from single biomarkers to re-wired networks |
| Q36635649 | Reciprocal Changes of Circulating Long Non-Coding RNAs ZFAS1 and CDR1AS Predict Acute Myocardial Infarction |
| Q38431496 | Reduced Circulating Levels of miR-433 and miR-133b Are Potential Biomarkers for Parkinson's Disease |
| Q34493653 | Regulation of microRNA-155 in atherosclerotic inflammatory responses by targeting MAP3K10 |
| Q36503183 | Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction |
| Q36460528 | SOX6 and PDCD4 enhance cardiomyocyte apoptosis through LPS-induced miR-499 inhibition |
| Q28817525 | Selective release of muscle-specific, extracellular microRNAs during myogenic differentiation |
| Q90701343 | Sensitive miRNA markers for the detection and management of NSTEMI acute myocardial infarction patients |
| Q64105308 | Sensory Neuropathy Affects Cardiac miRNA Expression Network Targeting , , , and mRNAs |
| Q54382302 | Serum miR-206 and other muscle-specific microRNAs as non-invasive biomarkers for Duchenne muscular dystrophy. |
| Q59532173 | Serum microRNA profiles in cats with hypertrophic cardiomyopathy |
| Q37516362 | Serum microRNA-499 and microRNA-208a as biomarkers of acute myocardial infarction |
| Q34704614 | Serum microRNAs profile from genome-wide serves as a fingerprint for diagnosis of acute myocardial infarction and angina pectoris |
| Q37027236 | Should we expect novel biomarkers of myocardial infarction? |
| Q38018832 | Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases |
| Q98177466 | Small Things Matter: Relevance of MicroRNAs in Cardiovascular Disease |
| Q50939526 | Soluble epoxide hydrolase inhibitors might prevent ischemic arrhythmias via microRNA-1 repression in primary neonatal mouse ventricular myocytes. |
| Q33677280 | Systemic approach to identify serum microRNAs as potential biomarkers for acute myocardial infarction |
| Q53306185 | Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine. |
| Q90695076 | The Diagnostic Value of Mir-133a in ST Elevation and Non-ST Elevation Myocardial Infarction: A Meta-Analysis |
| Q33624461 | The Role of MicroRNAs in Myocardial Infarction: From Molecular Mechanism to Clinical Application |
| Q35888026 | The biology of circulating microRNAs in cardiovascular disease. |
| Q53514132 | The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy. |
| Q57177487 | The circulating non-coding RNA landscape for biomarker research: lessons and prospects from cardiovascular diseases |
| Q38115783 | The complexity, function and applications of RNA in circulation |
| Q37119086 | The distribution of circulating microRNA and their relation to coronary disease |
| Q36603037 | The mix of two worlds: non-coding RNAs and hormones |
| Q50298511 | Therapeutic Potential of Modulating MicroRNA in Peripheral Artery Disease. |
| Q28478758 | Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer |
| Q26778915 | Translating extracellular microRNA into clinical biomarkers for drug-induced toxicity: from high-throughput profiling to validation |
| Q123271779 | Untargeted sequencing of circulating microRNAs in a healthy and diseased older population |
| Q64054235 | Upregulation of miR-29b-3p protects cardiomyocytes from hypoxia-induced apoptosis by targeting TRAF5 |
| Q28603219 | Uptake of dietary milk miRNAs by adult humans: a validation study |
| Q41359989 | Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases |
| Q99404614 | Value of Blood-Based microRNAs in the Diagnosis of Acute Myocardial Infarction: A Systematic Review and Meta-Analysis |
| Q40273642 | Vesicle-associated microRNAs are released from blood cells on incubation of blood samples |
| Q42862870 | Whether Circulating miRNAs or miRNA-Carriers Serve as Biomarkers for Acute Myocardial Infarction |
| Q35177245 | Wnt antagonist, secreted frizzled-related protein 1, is involved in prenatal skeletal muscle development and is a target of miRNA-1/206 in pigs |
| Q34505459 | miR-1 exacerbates cardiac ischemia-reperfusion injury in mouse models |
| Q93035290 | miR-1, miR-499 and miR-208 are sensitive markers to diagnose sudden death due to early acute myocardial infarction |
| Q41848371 | miR-200b is involved in intestinal fibrosis of Crohn's disease |
| Q33823007 | miR-499 protects cardiomyocytes from H 2O 2-induced apoptosis via its effects on Pdcd4 and Pacs2. |
| Q38110520 | miRNA in the regulation of ion channel/transporter expression |
| Q89019543 | miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges |
| Q92923058 | miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis |
| Q38221221 | miRNAs as non-invasive biomarkers for lung cancer diagnosis |
| Q37766212 | miRNAs as therapeutic targets in ischemic heart disease |
| Q37822463 | miRNAs: roles and clinical applications in vascular disease |
| Q27028108 | miRNome in myocardial infarction: Future directions and perspective |
| Q34456543 | miRandola: extracellular circulating microRNAs database |
| Q38379481 | microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts |
| Q37918622 | microRNAs as peripheral blood biomarkers of cardiovascular disease. |
| Q38375953 | microRNAs with different functions and roles in disease development and as potential biomarkers of diabetes: progress and challenges |
Search more.